Skip to main content

Implementing Preanalytical Tools That Improve Patient Care

Tracking # 20-1116298

Price not reported

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Conference
Dates Contact provider

Course overview

The Association for Diagnostics & Laboratory Medicine (formerly AACC) will hold its third Preanalytical Phase conference October 20 - 21, 2023, a 1.5-day educational conference, focusing on the preanalytical phase of laboratory processes with an emphasis on putting tools into practice to mitigate errors, reduce turnaround time, increase specimen quality, and improve patient care. Building on the success of previous preanalytical phase conferences, the program will be developed by renowned experts and provide timely education on the latest preanalytical phase topics in an engaging and interactive forum including poster sessions, networking events, and a sponsor-led educational symposium.

Subject areas

This course counts toward the state boards and subject areas below.

American Board of Clinical Chemistry

Clinical Chemistry Diplomate

10h Category 1

Molecular Diagnostics Diplomate

10h Category 1

Toxicological Chemistry Diplomate

10h Category 1

Florida Board of Clinical Laboratory Personnel

Clinical Laboratory Director

10h General

Clinical Laboratory Supervisor

10h General

Clinical Laboratory Technician

10h General

Clinical Laboratory Technologist

10h General

Public Health Director

10h General

Public Health Supervisor

10h General

Public Health Technologist

10h General

Disclosure statements

ADLM is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.


The following planners reported relevant financial relationships:

  • Chris Farnsworth, Chair: Consultant Fee: Biorad, Cytovale, Abbott; Lecture Fees (Honoraria, Speakers Bureau, etc.): Abbott
  • Joe El-Khoury: Consultant Fee: Siemens Healthineers, Thermo Fisher Scientific; Lecture Fees (Honoraria, Speakers Bureau, etc.): LabRoots; Grant support: Bioporto, IDEXX
  • Amy Pyle-Eilola: Consultant Fee: BD; Grant support: BD
  • Sarah Wheeler: Lecture Fees (Honoraria, Speakers Bureau, etc.): Siemens Healthineers


All ADLM staff involved in planning the program disclosed no relevant financial relationships. Faculty disclosures of relevant financial relationships will be provided in respective presentation and program materials.